Literature DB >> 33308661

Hydroxychloroquine and COVID-19 - A narrative review.

Jyoti Bajpai1, Akshyaya Pradhan2, Abhishek Singh3, Surya Kant4.   

Abstract

COVID 19 infection is unarguably the worst pandemic of this century. Till date there is no promising drug and vaccine available to treat this deadly viral infection. In the early phase chloroquine phosphate and hydroxychloroquine sulphate have been used to fight this illness on the basis of handful observational and small randomized and small-randomized studies. The paucity of clinical evidences of an unequivocal beneficial effect of chloroquine and hydroxychloroquine on COVID-19 has resulted in the passionate use of the drug for moderate to severe cases only and stimulated the need for large clinical trials for this and other molecules. In this review, we describe in brief the mechanism of action, the clinical studies, factors for cardiac toxicity, guidelines and future directions for hydroxychloroquine use in management of COVID-19 infection.
Copyright © 2020. Published by Elsevier B.V.

Entities:  

Keywords:  COVID-19; Hydroxychloroquine; Immunomodulator; Pandemic; QT prolongation

Year:  2020        PMID: 33308661     DOI: 10.1016/j.ijtb.2020.06.004

Source DB:  PubMed          Journal:  Indian J Tuberc        ISSN: 0019-5707


  1 in total

Review 1.  Use of hydroxychloroquine and azithromycin combination to treat the COVID-19 infection.

Authors:  Jyoti Bajpai; Akshyaya Pradhan; Ajay Kumar Verma; Surya Kant
Journal:  World J Exp Med       Date:  2022-05-20
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.